CVE-2025-3822

Public Exploit
SourceCodester Web-based Pharmacy Product Management System changepassword.php cross site scripting

Description

A vulnerability was found in SourceCodester Web-based Pharmacy Product Management System 1.0. It has been rated as problematic. This issue affects some unknown processing of the file changepassword.php. The manipulation of the argument txtconfirm_password/txtnew_password/txtold_password leads to cross site scripting. The attack may be initiated remotely. The exploit has been disclosed to the public and may be used.

Category

4.8
CVSS
Severity: Medium
CVSS 4.0 •
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.04%
Third-Party Advisory github.com Third-Party Advisory vuldb.com
Affected: SourceCodester Web-based Pharmacy Product Management System
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2025-3822?
CVE-2025-3822 has been scored as a medium severity vulnerability.
How to fix CVE-2025-3822?
To fix CVE-2025-3822, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2025-3822 being actively exploited in the wild?
It is possible that CVE-2025-3822 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2025-3822?
CVE-2025-3822 affects SourceCodester Web-based Pharmacy Product Management System.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.